Trojano M - Search Results

1

Mitochondria, Oxidative Stress, cAMP Signalling and Apoptosis: A Crossroads in Lymphocytes of Multiple Sclerosis, a Possible Role of Nutraceutics.

Signorile A, Ferretta A, Ruggieri M, Paolicelli D, Lattanzio P, Trojano M, De Rasmo D. Signorile A, et al. Among authors: trojano m. Antioxidants (Basel). 2020 Dec 28;10(1):21. doi: 10.3390/antiox10010021. Antioxidants (Basel). 2020. PMID: 33379309 Free PMC article. Review.

2

Age-related disability in multiple sclerosis.

Trojano M, Liguori M, Bosco Zimatore G, Bugarini R, Avolio C, Paolicelli D, Giuliani F, De Robertis F, Marrosu MG, Livrea P. Trojano M, et al. Ann Neurol. 2002 Apr;51(4):475-80. doi: 10.1002/ana.10147. Ann Neurol. 2002. PMID: 11921053

3

Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes.

Avolio C, Ruggieri M, Giuliani F, Liuzzi GM, Leante R, Riccio P, Livrea P, Trojano M. Avolio C, et al. Among authors: trojano m. J Neuroimmunol. 2003 Mar;136(1-2):46-53. doi: 10.1016/s0165-5728(03)00006-7. J Neuroimmunol. 2003. PMID: 12620642

4

Interferon beta in relapsing-remitting multiple sclerosis: an independent postmarketing study in southern Italy.

Trojano M, Liguori M, Paolicelli D, Zimatore GB, De Robertis F, Avolio C, Giuliani F, Fuiani A, Livrea P; Southern Italy MS Group. Trojano M, et al. Mult Scler. 2003 Oct;9(5):451-7. doi: 10.1191/1352458503ms948oa. Mult Scler. 2003. PMID: 14582768 Clinical Trial.

5

Age-related gadolinium-enhancement of MRI brain lesions in multiple sclerosis.

Tortorella C, Bellacosa A, Paolicelli D, Fuiani A, Di Monte E, Simone IL, Giaquinto P, Livrea P, Trojano M. Tortorella C, et al. Among authors: trojano m. J Neurol Sci. 2005 Dec 15;239(1):95-9. doi: 10.1016/j.jns.2005.08.006. Epub 2005 Oct 4. J Neurol Sci. 2005. PMID: 16209877

6

The Italian Multiple Sclerosis Database Network (MSDN): the risk of worsening according to IFNbeta exposure in multiple sclerosis.

Trojano M, Russo P, Fuiani A, Paolicelli D, Di Monte E, Granieri E, Rosati G, Savettieri G, Comi G, Livrea P; MSDN Study Group. Trojano M, et al. Mult Scler. 2006 Oct;12(5):578-85. doi: 10.1177/1352458506070620. Mult Scler. 2006. PMID: 17086903

7

New natural history of interferon-beta-treated relapsing multiple sclerosis.

Trojano M, Pellegrini F, Fuiani A, Paolicelli D, Zipoli V, Zimatore GB, Di Monte E, Portaccio E, Lepore V, Livrea P, Amato MP. Trojano M, et al. Ann Neurol. 2007 Apr;61(4):300-6. doi: 10.1002/ana.21102. Ann Neurol. 2007. PMID: 17444502 Clinical Trial.

8

Glatiramer acetate in multiple sclerosis: a review.

Ruggieri M, Avolio C, Livrea P, Trojano M. Ruggieri M, et al. Among authors: trojano m. CNS Drug Rev. 2007 Summer;13(2):178-91. doi: 10.1111/j.1527-3458.2007.00010.x. CNS Drug Rev. 2007. PMID: 17627671 Free PMC article. Review.

9

Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients.

Ruggieri M, Pica C, Lia A, Zimatore GB, Modesto M, Di Liddo E, Specchio LM, Livrea P, Trojano M, Avolio C. Ruggieri M, et al. Among authors: trojano m. J Neuroimmunol. 2008 Jul 15;197(2):140-6. doi: 10.1016/j.jneuroim.2008.04.032. Epub 2008 Jun 13. J Neuroimmunol. 2008. PMID: 18555539

10

Postmarketing evidence of disease-modifying drugs in multiple sclerosis.

Trojano M, Paolicelli D, Fuiani A, Pellegrini F, Iaffaldano P, Direnzo V, D'Onghia M. Trojano M, et al. Neurol Sci. 2008 Sep;29 Suppl 2:S225-6. doi: 10.1007/s10072-008-0944-z. Neurol Sci. 2008. PMID: 18690499 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

461 results

Search Page